Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imaging of Prostate Cancer Using Fluciclovine.
Savir-Baruch B, Zanoni L, Schuster DM. Savir-Baruch B, et al. Among authors: zanoni l. Urol Clin North Am. 2018 Aug;45(3):489-502. doi: 10.1016/j.ucl.2018.03.015. Epub 2018 Jun 15. Urol Clin North Am. 2018. PMID: 30031468 Review.
Nuclear medicine in urological cancers: what is new?
Nanni C, Zanoni L, Fanti S. Nanni C, et al. Among authors: zanoni l. Future Oncol. 2014 Oct;10(13):2061-72. doi: 10.2217/fon.14.87. Future Oncol. 2014. PMID: 25396777 Review.
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Nanni C, Zanoni L, Pultrone C, Schiavina R, Brunocilla E, Lodi F, Malizia C, Ferrari M, Rigatti P, Fonti C, Martorana G, Fanti S. Nanni C, et al. Among authors: zanoni l. Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1601-10. doi: 10.1007/s00259-016-3329-1. Epub 2016 Mar 10. Eur J Nucl Med Mol Imaging. 2016. PMID: 26960562 Clinical Trial.
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer.
Bach-Gansmo T, Nanni C, Nieh PT, Zanoni L, Bogsrud TV, Sletten H, Korsan KA, Kieboom J, Tade FI, Odewole O, Chau A, Ward P, Goodman MM, Fanti S, Schuster DM, Willoch F. Bach-Gansmo T, et al. Among authors: zanoni l. J Urol. 2017 Mar;197(3 Pt 1):676-683. doi: 10.1016/j.juro.2016.09.117. Epub 2016 Oct 13. J Urol. 2017. PMID: 27746282 Free PMC article.
Imaging of Prostate Cancer Using Fluciclovine.
Savir-Baruch B, Zanoni L, Schuster DM. Savir-Baruch B, et al. Among authors: zanoni l. PET Clin. 2017 Apr;12(2):145-157. doi: 10.1016/j.cpet.2016.11.005. Epub 2017 Jan 23. PET Clin. 2017. PMID: 28267449 Review.
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis.
Ghedini P, Bossert I, Zanoni L, Ceci F, Graziani T, Castellucci P, Ambrosini V, Massari F, Nobili E, Melotti B, Musto A, Zoboli S, Antunovic L, Kirienko M, Chiti A, Mosconi C, Ardizzoni A, Golfieri R, Fanti S, Nanni C. Ghedini P, et al. Among authors: zanoni l. Eur J Nucl Med Mol Imaging. 2018 May;45(5):751-758. doi: 10.1007/s00259-017-3888-9. Epub 2017 Nov 30. Eur J Nucl Med Mol Imaging. 2018. PMID: 29192364
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial.
Zanoni L, Bianchi L, Nanni C, Pultrone C, Giunchi F, Bossert I, Matti A, Schiavina R, Fiorentino M, Romagnoli D, Fonti C, Lodi F, D'Errico A, Brunocilla E, Porreca A, Fanti S. Zanoni L, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):390-409. doi: 10.1007/s00259-021-05429-6. Epub 2021 Jul 2. Eur J Nucl Med Mol Imaging. 2021. PMID: 34213609 Clinical Trial.
79 results